Comparison of circulating, hepatocyte specific messenger RNA and microRNA as biomarkers for chronic hepatitis B and C.

Circulating microRNAs have been widely recognized as a novel category of biomarker in a variety of physiological and pathological conditions. Other reports revealed that fragments of organ specific messenger RNAs are also detectable in serum/plasma and can be utilized as sensitive indicators of live...

Full description

Bibliographic Details
Main Authors: Xiaonan Zhang, Zhanqing Zhang, Fahui Dai, Bisheng Shi, Liang Chen, Xinxin Zhang, Guoqing Zang, Jiming Zhang, Xiaorong Chen, Fangxing Qian, Yunwen Hu, Zhenghong Yuan
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3958472?pdf=render
_version_ 1818137935790211072
author Xiaonan Zhang
Zhanqing Zhang
Fahui Dai
Bisheng Shi
Liang Chen
Xinxin Zhang
Guoqing Zang
Jiming Zhang
Xiaorong Chen
Fangxing Qian
Yunwen Hu
Zhenghong Yuan
author_facet Xiaonan Zhang
Zhanqing Zhang
Fahui Dai
Bisheng Shi
Liang Chen
Xinxin Zhang
Guoqing Zang
Jiming Zhang
Xiaorong Chen
Fangxing Qian
Yunwen Hu
Zhenghong Yuan
author_sort Xiaonan Zhang
collection DOAJ
description Circulating microRNAs have been widely recognized as a novel category of biomarker in a variety of physiological and pathological conditions. Other reports revealed that fragments of organ specific messenger RNAs are also detectable in serum/plasma and can be utilized as sensitive indicators of liver pathology and cancer. In order to assess the sensitivity and reliability of these two class of RNAs as marker of hepatitis B or C induced chronic liver disease, we collected plasma samples from 156 chronic hepatitis B or C patients (HBV active n = 112, HBV carrier n = 19, hepatitis C n = 25) and 22 healthy donors and quantified their circulating mRNA for albumin, HP (haptoglobin), CYP2E1 (cytochrome P450, family 2, subfamily E) and ApoA2 (Apolipoprotein A2) in conjunction with microRNA-122, a well established marker for acute and chronic liver injury. We found that plasma microRNA-122 level is significantly elevated in patients with active HBV but not in HBV carriers. Furthermore, microRNA-122 is not elevated in HCV patients even though their median serum alanine aminotransferase (sALT) was three fold of the healthy donors. Nevertheless, circulating mRNAs, especially albumin mRNA, showed much more sensitivity in distinguishing active hepatitis B, hepatitis B carrier or HCV patients from healthy control. Correlation and multiple linear regression analysis suggested that circulating mRNAs and miRNAs are much more related to HBsAg titre than to sALT. Immunoprecipitation of HBsAg in HBV patients' plasma resulted in enrichment of albumin and HP mRNA suggesting that fragments of liver specific transcripts can be encapsidated into HBsAg particles. Taken together, our results suggest that hepatocyte specific transcripts in plasma like albumin mRNA showed greater sensitivity and specificity in differentiating HBV or HCV induced chronic liver disease than microRNA-122. Circulating mRNA fragments merit more attention in the quest of next generation biomarkers for various maladies.
first_indexed 2024-12-11T10:04:13Z
format Article
id doaj.art-6c58716bdd8744de855df6a8704c5121
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-11T10:04:13Z
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-6c58716bdd8744de855df6a8704c51212022-12-22T01:12:01ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0193e9211210.1371/journal.pone.0092112Comparison of circulating, hepatocyte specific messenger RNA and microRNA as biomarkers for chronic hepatitis B and C.Xiaonan ZhangZhanqing ZhangFahui DaiBisheng ShiLiang ChenXinxin ZhangGuoqing ZangJiming ZhangXiaorong ChenFangxing QianYunwen HuZhenghong YuanCirculating microRNAs have been widely recognized as a novel category of biomarker in a variety of physiological and pathological conditions. Other reports revealed that fragments of organ specific messenger RNAs are also detectable in serum/plasma and can be utilized as sensitive indicators of liver pathology and cancer. In order to assess the sensitivity and reliability of these two class of RNAs as marker of hepatitis B or C induced chronic liver disease, we collected plasma samples from 156 chronic hepatitis B or C patients (HBV active n = 112, HBV carrier n = 19, hepatitis C n = 25) and 22 healthy donors and quantified their circulating mRNA for albumin, HP (haptoglobin), CYP2E1 (cytochrome P450, family 2, subfamily E) and ApoA2 (Apolipoprotein A2) in conjunction with microRNA-122, a well established marker for acute and chronic liver injury. We found that plasma microRNA-122 level is significantly elevated in patients with active HBV but not in HBV carriers. Furthermore, microRNA-122 is not elevated in HCV patients even though their median serum alanine aminotransferase (sALT) was three fold of the healthy donors. Nevertheless, circulating mRNAs, especially albumin mRNA, showed much more sensitivity in distinguishing active hepatitis B, hepatitis B carrier or HCV patients from healthy control. Correlation and multiple linear regression analysis suggested that circulating mRNAs and miRNAs are much more related to HBsAg titre than to sALT. Immunoprecipitation of HBsAg in HBV patients' plasma resulted in enrichment of albumin and HP mRNA suggesting that fragments of liver specific transcripts can be encapsidated into HBsAg particles. Taken together, our results suggest that hepatocyte specific transcripts in plasma like albumin mRNA showed greater sensitivity and specificity in differentiating HBV or HCV induced chronic liver disease than microRNA-122. Circulating mRNA fragments merit more attention in the quest of next generation biomarkers for various maladies.http://europepmc.org/articles/PMC3958472?pdf=render
spellingShingle Xiaonan Zhang
Zhanqing Zhang
Fahui Dai
Bisheng Shi
Liang Chen
Xinxin Zhang
Guoqing Zang
Jiming Zhang
Xiaorong Chen
Fangxing Qian
Yunwen Hu
Zhenghong Yuan
Comparison of circulating, hepatocyte specific messenger RNA and microRNA as biomarkers for chronic hepatitis B and C.
PLoS ONE
title Comparison of circulating, hepatocyte specific messenger RNA and microRNA as biomarkers for chronic hepatitis B and C.
title_full Comparison of circulating, hepatocyte specific messenger RNA and microRNA as biomarkers for chronic hepatitis B and C.
title_fullStr Comparison of circulating, hepatocyte specific messenger RNA and microRNA as biomarkers for chronic hepatitis B and C.
title_full_unstemmed Comparison of circulating, hepatocyte specific messenger RNA and microRNA as biomarkers for chronic hepatitis B and C.
title_short Comparison of circulating, hepatocyte specific messenger RNA and microRNA as biomarkers for chronic hepatitis B and C.
title_sort comparison of circulating hepatocyte specific messenger rna and microrna as biomarkers for chronic hepatitis b and c
url http://europepmc.org/articles/PMC3958472?pdf=render
work_keys_str_mv AT xiaonanzhang comparisonofcirculatinghepatocytespecificmessengerrnaandmicrornaasbiomarkersforchronichepatitisbandc
AT zhanqingzhang comparisonofcirculatinghepatocytespecificmessengerrnaandmicrornaasbiomarkersforchronichepatitisbandc
AT fahuidai comparisonofcirculatinghepatocytespecificmessengerrnaandmicrornaasbiomarkersforchronichepatitisbandc
AT bishengshi comparisonofcirculatinghepatocytespecificmessengerrnaandmicrornaasbiomarkersforchronichepatitisbandc
AT liangchen comparisonofcirculatinghepatocytespecificmessengerrnaandmicrornaasbiomarkersforchronichepatitisbandc
AT xinxinzhang comparisonofcirculatinghepatocytespecificmessengerrnaandmicrornaasbiomarkersforchronichepatitisbandc
AT guoqingzang comparisonofcirculatinghepatocytespecificmessengerrnaandmicrornaasbiomarkersforchronichepatitisbandc
AT jimingzhang comparisonofcirculatinghepatocytespecificmessengerrnaandmicrornaasbiomarkersforchronichepatitisbandc
AT xiaorongchen comparisonofcirculatinghepatocytespecificmessengerrnaandmicrornaasbiomarkersforchronichepatitisbandc
AT fangxingqian comparisonofcirculatinghepatocytespecificmessengerrnaandmicrornaasbiomarkersforchronichepatitisbandc
AT yunwenhu comparisonofcirculatinghepatocytespecificmessengerrnaandmicrornaasbiomarkersforchronichepatitisbandc
AT zhenghongyuan comparisonofcirculatinghepatocytespecificmessengerrnaandmicrornaasbiomarkersforchronichepatitisbandc